Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer. Zumsteg ZS. Int J Radiat Oncol Biol Phys 2022;112:744-746.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zumsteg ZS. Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2022;112:744-746.
PMID: 35101195